Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions
Author:
Affiliation:
1. Department of Thoracic Medicine and Surgery; Lewis Katz School of Medicine at Temple University; Philadelphia Pennsylvania USA
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13024/fullpdf
Reference26 articles.
1. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias;Am. J. Respir. Crit. Care Med.,2002
2. Clinical course and prediction of survival in idiopathic pulmonary fibrosis;Ley;Am. J. Respir. Crit. Care Med.,2011
3. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am. J. Respir. Crit. Care Med.,2011
4. Antifibrotic activities of pirfenidone in animal models;Schaefer;Eur. Respir. Rev.,2011
5. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy;Hilberg;Cancer Res.,2008
Cited by 186 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aerosol inhalation of total ginsenosides repairs acute lung injury and inhibits pulmonary fibrosis through SMAD2 signaling-mediated mechanism;Phytomedicine;2024-10
2. Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosis;Biomedicine & Pharmacotherapy;2024-09
3. Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan;Respiratory Investigation;2024-09
4. Therapeutic effects of flavonoids on pulmonary fibrosis: A preclinical meta-analysis;Phytomedicine;2024-09
5. The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: role of protonation-dependent crystallization processes;Chemico-Biological Interactions;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3